GSK Ventolin HFA roll-out
Executive Summary
Ventolin CFC version of inhalation asthma agent will be phased out in next 10 to 15 months following Feb. 20 launch of albuterol HFA, GlaxoSmithKline said. Ventolin HFA's wholesale acquisition cost will be same as its successor: $29.99 for 100 mcg. Ventolin HFA was approved in April 2001 (1"The Pink Sheet" April 23, 2001, p. 34)...